1. Home
  2. FUSE vs ATNM Comparison

FUSE vs ATNM Comparison

Compare FUSE & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FUSE

Fusemachines Inc.

N/A

Current Price

$1.41

Market Cap

40.8M

Sector

Technology

ML Signal

N/A

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.17

Market Cap

42.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FUSE
ATNM
Founded
2013
2000
Country
United States
United States
Employees
270
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.8M
42.0M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
FUSE
ATNM
Price
$1.41
$1.17
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.50
AVG Volume (30 Days)
149.6K
108.9K
Earning Date
06-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.17
EPS
N/A
N/A
Revenue
N/A
$90,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.11
52 Week Low
$0.80
$0.95
52 Week High
$3.67
$1.95

Technical Indicators

Market Signals
Indicator
FUSE
ATNM
Relative Strength Index (RSI) 45.53 45.36
Support Level $1.28 $0.99
Resistance Level $1.50 $1.25
Average True Range (ATR) 0.15 0.07
MACD -0.03 -0.01
Stochastic Oscillator 26.32 8.70

Price Performance

Historical Comparison
FUSE
ATNM

About FUSE Fusemachines Inc.

Fusemachines Inc is a provider of enterprise AI solutions, offering products such as AI Studio, AI Engines, and AI Agents, along with supporting services across various industries. Its solutions are supported by a talent pool from underserved communities, enabling scalable and high-quality AI delivery while promoting access to AI. The Company serves clients across industries, including healthcare, media, technology, and government, helping address challenges such as improving forecasting accuracy, reducing data entry errors, automating recruitment, and detecting fraud. Its product suite includes AI Studio, AI Engines, and AI Agents, designed to build, deploy, and scale AI solutions, and it operates in Nepal and the United States.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.

Share on Social Networks: